Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer.
Journal: Science immunology
Published: April 03, 2026
Long-Term Survival Outcomes of Immune Checkpoint Inhibitor-based Combination Therapies in Favorable-Risk Metastatic Renal Cell Carcinoma: An Updated Pairwise and Network Meta-Analysis.
Journal: Clinical genitourinary cancer
Published: March 09, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing.
Journal: Nature communications
Published: November 05, 2025
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.
Journal: Future oncology (London, England)
Published: January 11, 2025
Conservation and divergence of metabolic phenotypes between patient tumours and matched xenografts.
Journal: Nature metabolism
Published: September 08, 2024
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development.
Journal: Cancer immunology research
Published: August 19, 2024
Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes.
Journal: Nature cancer
Published: July 15, 2024
Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2024
pan-MHC and cross-Species Prediction of T Cell Receptor-Antigen Binding.
Journal: bioRxiv : the preprint server for biology
Published: December 18, 2023
Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice.
Journal: Frontiers in immunology
Published: December 06, 2023
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Journal: The Lancet. Oncology
Published: July 31, 2023
Last Updated: 09/26/2026